Back to
DRIEHAUS CAPITAL MANAGEMENT LLC
HALO17 quarters
Position history for
DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in HALOZYME THERAPEUTICS INC
No. Driehaus Capital Management exited its HALO (Halozyme Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 331,703 shares worth $12.3M. Driehaus Capital Management first reported HALO in Q1 2020 and held it in 16 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$4.3M
Total Shares Change
-239,531
Quarter-by-Quarter History
Other major holders of HALO: BlackRock, Inc., BlackRock Finance, Inc.